{
    "id": "0981",
    "question": "A 22-year-old woman presents to her primary care physician in April for seasonal allergies. She has suffered from seasonal allergies for the past 2 years and takes diphenhydramine as needed when her symptoms worsen. She has not yet seen a physician for her allergies. She reports that diphenhydramine has been helpful in controlling her symptoms, but she does not like feeling drowsy from the medication. Her past medical history is also notable for well-controlled asthma. She uses an albuterol inhaler on an as-needed basis. She smokes marijuana daily. Her temperature is 99.2\u00b0F (37.3\u00b0C), blood pressure is 120/70 mmHg, pulse is 76/min, and respirations are 16/min. She has a prominent nasal crease. Her nasal turbinates are boggy and bluish-gray. She has copious thin and watery nasal mucus. The physician suggests replacing diphenhydramine with fexofenadine to improve her drowsiness. What characteristic of fexodenadine allows it to be less sedating than diphenhydramine?",
    "options": {
        "A": "Alpha-adrenergic antagonism",
        "B": "Beta-adrenergic antagonism",
        "C": "Relative lipophobicity",
        "D": "Serotonergic antagonism"
    },
    "answer": "C",
    "predict": "To answer this question, let's break down the key points: 1. The patient is looking for a non-sedating antihistamine to replace diphenhydramine due to its sedating side effects. 2. The physician suggests fexofenadine as an alternative. 3. We need to identify the characteristic of fexofenadine that makes it less sedating than diphenhydramine. Now, let's examine the options: A. Alpha-adrenergic antagonism: This is not directly related to the sedating effects of antihistamines. Alpha-adrenergic antagonists are actually a class of medications used to treat hypertension and other conditions, not antihistamines. B. Beta-adrenergic antagonism: This is also not relevant to the sedating effects of antihistamines. Beta-adrenergic antagonists are used to treat conditions like hypertension, angina, and certain arrhythmias. C. Relative lipophobicity: This term refers to the ability of a molecule to pass through cell membranes, specifically the blood-brain barrier. Non-lipophilic (lipophobic) molecules are less likely to cross the blood-brain barrier, which in turn reduces the risk of sedation. Fexofenadine is known to be more lipophobic than diphenhydramine, which allows it to be less sedating. D. Serotonergic antagonism: While some antihistamines can have serotonergic effects, this is not the primary reason why fexofenadine is less sedating than diphenhydramine. Based on this analysis, the characteristic of fexofenadine that allows it to be less sedating than diphenhydramine is its relative lipophobicity. {\"step_by_step_thinking\": \"The key difference between fexofenadine and diphenhydramine lies in their lipophobicity. Fexofenadine is more lipophobic, which reduces its ability to cross the blood-brain barrier and subsequently minimizes its sedating effects. This characteristic makes it a suitable alternative for patients who experience sedation with diphenhydramine.\", \"answer_choice\": \"C\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 22.766445636749268
}